Trisolini R.; Cancellieri A.; Livi V.; Annema J.T.; Ferrari M.; Natali F.; Paioli D.; Conci N.; Altimari A.; Fiorentino M.; Ardizzoni A., Pulmonary adenocarcinoma with psammoma bodies is associated with a specific endobronchial ultrasound pattern and a high prevalence of actionable driver mutations, «LUNG CANCER», 2020, 147, pp. 204 - 208 [articolo]
Ricci C.; Capizzi E.; Giunchi F.; Casolari L.; Gelsomino F.; Rihawi K.; Natali F.; Livi V.; Trisolini R.; Fiorentino M.; Ardizzoni A., Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2020, 12, Article number: 1758835920954802, pp. 1 - 8 [articolo]Open Access
Droghetti, Matteo; Ercolino, Amelio; Piazza, Pietro; Bianchi, Lorenzo; Fabbrizio, Benedetta; Giunchi, Francesca; Mineo Bianchi, Federico; Barbaresi, Umberto; Casablanca, Carlo; Tonin, Elena; Mottaran, Angelo; Fiorentino, Michelangelo; Schiavina, Riccardo; Brunocilla, Eugenio, Secondary bladder amyloidosis due to Crohn's disease: a case report and literature review, «CEN CASE REPORTS», 2020, 9, pp. 413 - 417 [articolo]
Giunchi F.; Franceschini T.; Gruppioni E.; Altimari A.; Capizzi E.; Massari F.; Schiavina R.; Brunelli M.; Martignoni G.; Fiorentino M., Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis, «DIAGNOSTICS», 2020, 10, Article number: 123, pp. 123 - 123 [articolo]Open Access
Giunchi, Francesca; Gevaert, Thomas; Scarpelli, Marina; Fiorentino, Michelangelo, Status of Programmed Death Ligand 1 (PD-L1) by immunohistochemistry and scoring algorithms, «CURRENT DRUG TARGETS», 2020, 21, pp. 1 - 1 [articolo]
Stopsack K.H.; Gerke T.; Zareba P.; Pettersson A.; Chowdhury D.; Ebot E.M.; Flavin R.; Finn S.; Kantoff P.W.; Stampfer M.J.; Loda M.; Fiorentino M.; Mucci L.A., Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer, «CARCINOGENESIS», 2020, 41, pp. 904 - 908 [articolo]
Bianchi L, Schiavina R, Borghesi M, Chessa F, Casablanca C, Angiolini A, Ercolino A, Pultrone CV, Mineo Bianchi F, Barbaresi U, Piazza P, Manferrari F, Bertaccini A, Fiorentino M, Ferro M, Porreca A, Marcelli E, Brunocilla E, Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique, «MINERVA UROLOGICA E NEFROLOGICA», 2020, 72, pp. 339 - 349 [articolo]
Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F, A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss., «MOLECULAR DIAGNOSIS & THERAPY», 2019, 23, pp. 569 - 577 [articolo]
Zhang, Yiwen; Zhou, Cindy Ke; Rencsok, Emily M; Fall, Katja; Lotan, Tamara L; Loda, Massimo; Giunchi, Francesca; Platz, Elizabeth A; De Marzo, Angelo M; Mucci, Lorelei A; Fiorentino, Michelangelo; Ebot, Ericka M, A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal Prostate Cancer, «CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION», 2019, 28, pp. 2047 - 2054 [articolo]
Pernar, Claire H.*; Ebot, Ericka M.; Pettersson, Andreas; Graff, Rebecca E.; Giunchi, Francesca; Ahearn, Thomas U.; Gonzalez-Feliciano, Amparo G.; Markt, Sarah C.; Wilson, Kathryn M.; Stopsack, Konrad H.; Gazeeva, Elizaveta; Lis, Rosina T.; Parmigiani, Giovanni; Rimm, Eric B.; Finn, Stephen P.; Giovannucci, Edward L.; Fiorentino, Michelangelo; Mucci, Lorelei A., A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG, «EUROPEAN UROLOGY», 2019, 76, pp. 33 - 40 [articolo]
Livi, Vanina; Ardizzoni, Andrea; Cancellieri, Alessandra; Natali, Filippo; Ferrari, Marco; Paioli, Daniela; De Biase, Dario; Capizzi, Elisa; Tallini, Giovanni; Fiorentino, Michelangelo; Trisolini, Rocco, Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer, «THE CLINICAL RESPIRATORY JOURNAL», 2019, 13, pp. 590 - 597 [articolo]
Di Nunno V.; Frega G.; Santoni M.; Gatto L.; Fiorentino M.; Montironi R.; Battelli N.; Brandi G.; Massari F., BAP1 in solid tumors, «FUTURE ONCOLOGY», 2019, 15, pp. 2151 - 2162 [articolo]
Repaci, Andrea; Vicennati, Valentina; Paccapelo, Alexandro; Cavicchi, Ottavio; Salituro, Nicola; Monari, Fabio; de Biase, Dario; Tallini, Giovanni; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Pagotto, Uberto, BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma, «INTERNATIONAL JOURNAL OF ENDOCRINOLOGY», 2019, 2019, Article number: 3081497, pp. 1 - 7 [articolo]Open Access
Broccoli, Alessandro; Bertuzzi, Clara; Fiorentino, Michelangelo; Morigi, Alice; Stefoni, Vittorio; Agostinelli, Claudio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia, «ONCOTARGETS AND THERAPY», 2019, 12, Article number: 12, pp. 4807 - 4812 [articolo]Open Access
Capizzi E.; Dall'Olio F.G.; Gruppioni E.; Sperandi F.; Altimari A.; Giunchi F.; Fiorentino M.; Ardizzoni A., Clinical significance of ROS1 5’ deletions in non-small cell lung cancer, «LUNG CANCER», 2019, 135, pp. 88 - 91 [articolo]
